T-cell prolymphocytic leukemia, a case report and review of the literature.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
Works matching IS 09650407 AND DT 2025 AND VI 33 AND IP 3
Results: 22
1
2
Retraction: MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis.
- Published in:
- 2025
- Publication type:
- Correction Notice
3
Retraction: miR-641 functions as a tumor suppressor by targeting MDM2 in human lung cancer.
- Published in:
- 2025
- Publication type:
- Correction Notice
4
Retraction: miR-144-3p targets FosB proto-oncogene, AP-1 transcription factor subunit (FOSB) to suppress proliferation, migration, and invasion of PANC-1 pancreatic cancer cells.
- Published in:
- 2025
- Publication type:
- Correction Notice
5
Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1.
- Published in:
- 2025
- Publication type:
- Correction Notice
6
Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
7
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 723, doi. 10.32604/or.2024.056282
- By:
- Publication type:
- Article
8
Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2<sup>V617F</sup> mutation in myeloproliferative neoplasms.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 675, doi. 10.32604/or.2024.056256
- By:
- Publication type:
- Article
9
Biomarkers for predicting bladder cancer therapy response.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
10
Ultrasound genomics related mitochondrial gene signature for prognosis and neoadjuvant chemotherapy resistance in triple negative breast cancer.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 631, doi. 10.32604/or.2024.054642
- By:
- Publication type:
- Article
11
Magnetic melamine cross-linked polystyrene-alt-malic anhydride copolymer: Synthesis, characterization, paclitaxel delivery, cytotoxic effects on human ovarian and breast cancer cells.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 665, doi. 10.32604/or.2024.054487
- By:
- Publication type:
- Article
12
Research progress on the role of decorin in the development of oral mucosal carcinogenesis.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
13
Preventive effects of low-dose radiation and hypofractionated radiation plus anti-programmed cell death protein 1 on lung metastasis in breast cancer.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 687, doi. 10.32604/or.2024.052133
- By:
- Publication type:
- Article
14
Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
15
ICAT mediates the inhibition of stemness and tumorigenesis in acute myeloid leukemia cells induced by 1,25-(OH)<sub>2</sub>D<sub>3</sub>.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 695, doi. 10.32604/or.2024.051746
- By:
- Publication type:
- Article
16
Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
17
Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expression.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 605, doi. 10.32604/or.2024.050661
- By:
- Publication type:
- Article
18
The regulatory role of ZFAS1/ miRNAs/mRNAs axis in cancer: a systematic review.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
19
Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 653, doi. 10.32604/or.2024.050182
- By:
- Publication type:
- Article
20
CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transition.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 709, doi. 10.32604/or.2024.050125
- By:
- Publication type:
- Article
21
A novel prognostic scoring model based on cuproptosis identifies COMMD1 as a novel therapy target for liver hepatocellular carcinoma.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 617, doi. 10.32604/or.2024.049772
- By:
- Publication type:
- Article
22
Astragalus polysaccharide enhances the therapeutic efficacy of cisplatin in triple-negative breast cancer through multiple mechanisms.
- Published in:
- Oncology Research, 2025, v. 33, n. 3, p. 641, doi. 10.32604/or.2024.050057
- By:
- Publication type:
- Article